1. Home
  2. LVO vs CTSO Comparison

LVO vs CTSO Comparison

Compare LVO & CTSO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo LiveOne Inc.

LVO

LiveOne Inc.

HOLD

Current Price

$5.15

Market Cap

53.9M

ML Signal

HOLD

Logo Cytosorbents Corporation

CTSO

Cytosorbents Corporation

HOLD

Current Price

$0.67

Market Cap

45.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LVO
CTSO
Founded
2009
1997
Country
United States
United States
Employees
N/A
N/A
Industry
Restaurants
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
53.9M
45.9M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
LVO
CTSO
Price
$5.15
$0.67
Analyst Decision
Strong Buy
Buy
Analyst Count
1
2
Target Price
$13.00
$5.38
AVG Volume (30 Days)
100.5K
114.9K
Earning Date
11-12-2025
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$86,702,000.00
$36,979,520.00
Revenue This Year
N/A
$9.51
Revenue Next Year
$28.01
$24.40
P/E Ratio
N/A
N/A
Revenue Growth
N/A
23.89
52 Week Low
$3.92
$0.60
52 Week High
$16.00
$1.61

Technical Indicators

Market Signals
Indicator
LVO
CTSO
Relative Strength Index (RSI) 59.28 43.59
Support Level $4.99 $0.66
Resistance Level $5.49 $0.76
Average True Range (ATR) 0.35 0.07
MACD 0.06 -0.00
Stochastic Oscillator 73.02 24.33

Price Performance

Historical Comparison
LVO
CTSO

About LVO LiveOne Inc.

LiveOne Inc, formerly LiveXLive Media Inc is a premium internet network devoted to live music and music-related video content. The company has been building an online destination for music fans to enjoy live performances from music venues and music festivals around the world, such as Rock in Rio, Outside Lands Music and Arts Festival, and Hangout Music Festival, as well as original content, artist exclusives, and industry interviews. The Company operates mainly through three segments, PodcastOne, Slacker, and Media Group, with a majority of its revenue derived from the Slacker segment.

About CTSO Cytosorbents Corporation

CytoSorbents Corp specializes in treating life-threatening conditions in intensive care and cardiac surgery using proprietary polymer adsorption technology. Its flagship product, CytoSorb, is approved in the EU as an extracorporeal cytokine absorber, aiming to reduce inflammation and prevent multiple organ failure in critical illnesses like sepsis and trauma. Revenue primarily comes from product sales in Germany, with additional income from grant agencies in the United States. The company operates through Direct sales and Distributors/strategic partners in United States, Germany and Other Countries. The company's product consists of Cytosorb, ECOS-300CY, VetResQ, HemoDefend, and DrugSorb-ATR.

Share on Social Networks: